Position statement on the use of bone turnover markers for osteoporosis treatment

So Young Park, Seong Hee Ahn, Jun Il Yoo, Youn Jee Chung, Yun Kyung Jeon, Byung Ho Yoon, Ha Young Kim, Seung Hun Lee, Jehoon Lee, Seongbin Hong

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations


Current evidences continue to support the clinical application of bone turnover markers (BTMs) in the management of postmenopausal osteoporosis. The limitations of bone mineral density measured by dual energy X-ray absorptiomet especially emphasize the beneficial roles of BTMs, such as serum C-terminal telopeptide of type I collagen and serum procollagen type I N-propeptide, as monitoring tools to assess the responses to treatment. Therefore, the proper application and assessment of BTM in clinical practice is very important. However, their use in Korea is still insufficient. Therefore, the BTM committee has set up by the Korean Society for Bone and Mineral Research have been constituted and provided a position statement which will suggest on the clinical application of BTM for the management of postmenopausal osteoporosis in Korea.

Original languageEnglish
Pages (from-to)213-224
Number of pages12
JournalJournal of Bone Metabolism
Issue number4
StatePublished - 2019

Bibliographical note

Publisher Copyright:
Copyright © 2019 The Korean Society for Bone and Mineral Research.


  • Bone remodeling
  • Osteoporosis
  • Republic of Korea


Dive into the research topics of 'Position statement on the use of bone turnover markers for osteoporosis treatment'. Together they form a unique fingerprint.

Cite this